GRB7 anticorps (C-Term)
Aperçu rapide pour GRB7 anticorps (C-Term) (ABIN966220)
Antigène
Voir toutes GRB7 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Purification
- Purified by antigen-specific affinity chromatography.
-
Immunogène
- Polyclonal antibody produced in rabbits immunizing with a synthetic peptide corresponding to C-terminal residues of human Growth factor receptor-bound protein 7 (GRB7 adapter protein) or Epidermal growth factor receptor GRB-7 (B47).
-
-
-
-
Indications d'application
- ELISA, Western blotting: 1µg/ml for 2hrs.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- This antibody is stored in PBS, 50% glycerol
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
-
- GRB7 (Growth Factor Receptor-Bound Protein 7 (GRB7))
-
Autre désignation
- GRB7 (Growth factor receptor-bound protein 7)
-
Sujet
- GRB7(Growth factor receptor-bound protein 7) is a potential signal transduction molecule, and a variant of human Grb7 which is associated with invasive esophageal carcinoma. GRB7 interacts with the cytoplasmic domain of the epidermal growth factor receptor which is then inhibited. The interaction is mediated by the SH2 domain. GRB7 also binds to ERBB2 and interacts with RND1. GRB7 belongs to the GRB7/10/14 family and contains 1 PH domain, 1 Ras-associating domain and 1 SH2 domain.
-
Pathways
- EGFR Signaling Pathway, Ribonucleoprotein Complex Subunit Organization
Antigène
-